October 8, 2026

FDA Completes Mifepristone Safety Study by December 2023, Final Report by March 2027

The FDA expects to complete its safety study of mifepristone by mid-December 2023.
A final report on the findings will be issued no later than March 2027, which may lead to new restrictions on the drug's use.
The review is part of a legal response to ongoing lawsuits regarding mifepristone's distribution and safety, including challenges from states like Louisiana.

Read the news this way every day.

Concur organizes political reporting into clear stories and shows the sources behind each one.

Free. No ads.